Two-Day Event to be Held on 4-5 November. Bringing Together Global Investors and Entrepreneurs to Explore New Frontiers in Agentic AI, One-Person Companies (OPCs), and Hong Kong’s Role as an International Innovation, Funding, and Technology Hub
Updated
October 30, 2026 9:22 PM
.jpg)
Hong Kong, 26 October 2026 – As the global venture capital market evolves amid economic shifts, investment flows are increasingly concentrated, particularly in artificial intelligence (AI), which continues to drive significant momentum. The annual flagship event, Cyberport Venture & Capital Forum (CVCF), will take place on 4-5 November 2026 at Cyberport. Themed “Scaling in a Changing World: Winning the Next Competitive Cycle”, this year’s CVCF will unite influential global investors and entrepreneurs to explore key themes including Enterprise and Agentic AI, One-Person Companies (OPCs), frontier technologies, and spotlight Hong Kong's unique position as a strategic gateway connecting Chinese Mainland, ASEAN, the Middle East, global innovation and funding networks. The forum aims to empower start-ups and investors to break through financing and market expansion barriers, seizing new market opportunities.
.jpg)
Dr Rocky Cheng, CEO of Cyberport, said, “As global innovation and capital markets undergo accelerated reshaping, AI, data technology, and emerging industries have become crucial engines driving economic growth. CVCF is dedicated to building a bridge between innovation and capital. This year’s forum focuses on new trends such as AI, digital assets, and One-Person Companies (OPCs), exploring emerging market opportunities and global expansion strategies. It decodes how enterprises can drive scalable growth with speed and resilience in a rapidly changing market. Through our investor matching activities, we aim to facilitate the commercialisation of innovations and cross-regional collaboration. Cyberport will continue to leverage its role as Hong Kong’s digital tech flagship and AI accelerator to foster a thriving I&T ecosystem and inject new momentum into building Hong Kong as an international innovation and technology hub.”
Cyberport’s start-ups have demonstrated robust fundraising performance over the past year. With 481 companies joining the community during this period, Cyberport start-ups have raised over HK$74.5 billion in funding. During the year, 19 Cyberport companies successfully listed, alongside the addition of 2 new unicorns. Recent high-value fundraising rounds include Finloop, Qupital, Premialab, and Buy&Ship, many of which leverage AI, blockchain, and digital assets - reflecting sustained market confidence in these emerging technologies and underscoring Cyberport's success in fostering their development.
.jpg)
Hendrick Sin, Chairman of Cyberport Investors Network (CIN) Steering Group; Co-Founder of CMGE Technology Group Limited; Chairman of China Prosperity Capital, said, “Cyberport Investors Network (CIN) has come to its 9th anniversary this year, and our network of over 240 global investors has successfully facilitated more than HK$6 billion across over 133 project matchings, representing an increase of over 19 projects compared to last year. Simultaneously, the Cyberport Macro Fund (CMF), alongside co-investments, has directed HK$2.7 billion into high-potential ventures, with a co-investment ratio of 1:9:3., reflecting strong investor confidence in Cyberport companies. Through dedicated initiatives and our targeted investor matching sessions, CVCF continues to bridge high-growth ventures with institutional co-investment partners, public-private funds and foster collaboration across government, industry, academia, research, investment, and users, propelling enterprise scale across regional corridors.”
As Hong Kong’s digital tech hub, AI accelerator and key incubator, Cyberport leverages the Cyberport Investors Network (CIN) to attract influential investment units from around the world to connect with high-potential Cyberport enterprises to accelerate their development. Since its inception in 2017, the total investments facilitated by CIN have reached over HK$6 billion across a cumulative total of 133 project matchings. CIN’s investment units have surpassed 240, with 15% from the Greater Bay Area and 14% from the Asia-Pacific region, alongside continuous expansion into the Middle East and ASEAN, successfully aggregating global venture capital.
Another key financing channel, Cyberport Macro Fund (CMF), continues to invest in high-potential start-ups while enhancing their fundraising capabilities. As of September 2026, CMF has invested in 30 start-up projects, with the total investment, including co-investments, exceeding HK$2.7 billion, with a co-investment ratio of 1:9.3 — meaning every HK$1 invested by Cyberport attracts an additional HK$9.3 in co-investment. Further augmenting ecosystem liquidity, Cyberport, BOCHK Asset Management, and BOC Group Investment have formed a strategic partnership in May 2026 around a completed venture capital fund to back promising Hong Kong I&T start-ups. This demonstrates Cyberport’s sustained ability to attract and secure capital in a challenging environment.
Cyberport companies have recently achieved remarkable success across venture capital fundraising, advanced technology commercialisation, and international market expansion. Among them, leading Cyberport community members, including global Web5 wealth technology platform Finloop, independent fintech and data analytics platform Premialab, and cross-border fintech platform Qupital, shared their insights on navigating capital cycles, deploying next-generation financial architectures, and scaling from Hong Kong into regional and global markets.
Zhao Yang, Deputy CEO of Finloop, said, “While originating from an established corporate background, we strategically chose Cyberport as the ideal launchpad to spin off our project and scale our vision. Cyberport has been an indispensable catalyst for Finloop’s growth as we develop our AI-driven, one-stop Web5 wealth technology and RWA issuance platform, delivering AI-native liquidity solutions to institutions and SMEs. Beyond providing a vibrant community of innovators, Cyberport’s dynamic ecosystem provides an invaluable springboard for us with leading commercial banks, brokerages, and External Asset Managers (EAMs) across Hong Kong and Singapore, accelerating our mission to build compliant and institutional-grade infrastructure that unlocks new liquidity and value flows across the region.”
Pierre Trecourt, Co-Founder and Chief Operating Officer of Premialab, emphasized the growing importance of advanced data analytics in multi-asset investing, “In an increasingly complex and volatile market environment, institutional investors need greater transparency and sophisticated analytics to construct resilient portfolios, benchmark systematic investment strategies, and manage risk. Hong Kong’s unique position as a global financial hub, combined with its exceptional talent pool and Cyberport’s extensive ecosystem, provides an ideal environment for fintech companies to innovate, expand internationally, and scale their businesses.”
Winston Wong, Co-Founder and CEO of Qupital, discussed their milestone achievements in digital economy lending and underscored Cyberport’s long-standing backing throughout their journey, “Cyberport has played an integral role throughout Qupital’s journey from a homegrown startup to a profitable Series C fintech company. Under the support of Cyberport’s investor networks and platforms, we are proud to have become the first platform in Asia to securitise e-commerce merchant loans while sustaining industry-leading credit performance and profitability. Our journey truly reflects how Cyberport empowers homegrown fintech pioneers to scale sustainable cross-border supply chain financing across the Greater Bay Area and global markets.”
Cyberport Venture & Capital Forum 2026 will feature opening remarks by Lillian Cheong, Acting Secretary for Innovation, Technology and Industry, and bring together venture capital leaders, including representatives from Taara, Gobi Partners, Alumni Ventures, Rasmal Ventures, Primavera Capital, Draper Dragon, Pegasus Tech Ventures, Plug & Play and more to discuss the latest technology and market focus:
CVCF 2026 will continue to feature the popular “Investor Matching” session, offering face-to-face and online interactions to pair investors with start-ups based on their technological focus and investment preferences, enhancing collaboration efficiency. Additional highlights include over 80 physical showcase booths, funder power pitches, start-up clinic & workshop, providing attendees with practical insights and strategic advice. Memorandum of Understanding (MoU) signing ceremonies between Cyberport and international partners including Gobi Partners and Thailand’s National Innovation Agency (NIA) will also be held on the day.
The Agentic Economy Summit, a key highlight of the forum, will feature a keynote speech from Mr Joseph CHAN, JP, Under Secretary for Financial Services and the Treasury, bringing together AI pioneers, regulators, and financial giants to examine how digital identity, institutional tokenisation, HKD stablecoin issuance, programmable payments and machine-to-machine commerce are building the financial rails of the future. Featured speakers will also include representatives from HashKey, Cobo, Unlimit, Anchorpoint, UBS, Monk’s Hill Ventures, and more. The summit will also be exploring the emerging phenomenon of One-Person Companies (OPCs), highlighting how AI agents enable lean entrepreneurial ventures to achieve unprecedented operational scale.
As Cyberport’s flagship venture capital event, CVCF connects investors and entrepreneurs in the global digital technology. In 2025, the hybrid event attracted over 2,700 participants, achieved more than 180,000 views and facilitated more than 500 deal flows, fostering partnerships and investment opportunities. For more details, please visit the website: http://cvcf.cyberport.hk/.
The annual flagship event, Cyberport Venture Capital Forum (CVCF) 2026, will take place on 4-5 November 2026 at Cyberport. Themed “Scaling in a Changing World: Winning the Next Competitive Cycle”, this year’s CVCF will unite influential global investors and entrepreneurs to explore key themes include Enterprise AI, One-Person Companies (OPCs), frontier technologies, and spotlight Hong Kong's unique position as a strategic gateway connecting Chinese Mainland, ASEAN, the Middle East, global innovation and funding networks. The forum aims to empower start-ups and investors to break through financing and market expansion barriers, seizing new market opportunities. Dr Rocky Cheng, CEO of Cyberport (third right), Hendrick Sin, Chairman of Cyberport Investors Network (CIN) Steering Group (third left); Ir Eric Chan, Chief Public Mission Officer of Cyberport (second right), and Cyberport community members, Zhao Yang, Deputy CEO of Finloop (second left), Pierre Trecourt, Co-Founder and Chief Operating Officer of Premialab (first right), and Winston Wong, Co-Founder and CEO of Qupital (first left), attended the media briefing.
.jpg)
Ir Eric Chan, Chief Public Mission Officer of Cyberport introduced the speakers and highlights of the two-day Cyberport Venture Capital Forum 2025, as well as the Web3.0 Innovation Expo.
.jpg)
Ir Eric Chan, Chief Public Mission Officer of Cyberport (first left) and Cyberport community members, Zhao Yang, Deputy CEO of Finloop (second left), Pierre Trecourt, Co-Founder and Chief Operating Officer of Premialab (second right), and Winston Wong, Co-Founder and CEO of Qupital (first right), shared investment insights and experiences in facilitating fundraising during the discussion session.
Keep Reading
The Canberra biotech startup is helping processors detect spoilage risks before milk reaches the shelf.
Updated
August 13, 2026 1:01 AM
CYBERTONGUE® Food Testing System, developed by PPB Technology. IMAGE: PPB Technology
Anyone who has opened a carton of milk before its expiry date only to find that it smells off or tastes bitter has experienced the problem firsthand. For dairy processors, the same issue can play out across thousands of litres. Milk may pass routine quality checks, make it through production and still spoil before reaching the end of its expected shelf life.
CYBERTONGUE®, a biosensing platform, is designed to give dairy processors an earlier warning.
Developed by Canberra-based biotech startup PPB Technology, the compact food testing system allows processors to analyse milk on-site and receive results within minutes. Its first commercial application detects protease, an enzyme linked to spoilage, shorter shelf life and production losses across dairy products.
Dairy companies already test milk for fat, protein, bacteria, antibiotics and other indicators. Samples from individual farms may be sent to central laboratories, while tanker loads are tested again when they reach processing plants. These checks provide useful information, but they do not always show whether milk will remain stable in a UHT carton, meet a supermarket’s shelf-life requirements or produce the expected amount of cheese.
Even after heat treatment, protease can continue affecting milk. For processors making UHT milk, fresh milk or mature cheese, that creates a costly blind spot.
“Right now, dairy processors are working blind on this,” PPB Technology founder Stephen Trowell told Ventureport. “It’s becoming more of a problem as customers expect longer shelf lives and higher quality.”
CYBERTONGUE® uses engineered biosensing proteins that emit blue and green light. The balance between the two colours changes when the protein reacts with a target substance. The reader measures that shift and calculates how much of the target is present.
Trowell describes himself as a protein engineer at heart. He spent around three decades at CSIRO, Australia's national science and technology agency, and close to four decades in research before becoming a startup founder. The technology behind CYBERTONGUE® grew out of years of biological research, including earlier experiments involving wine aromas and explosives detection.
PPB initially developed its technology to measure plasmin, an enzyme derived from cows. After feedback from the dairy industry, the company shifted its focus to bacterial proteases, which were identified as a more pressing spoilage problem. The platform can make some existing tests faster, but PPB chose to focus first on a measurement previously unavailable to processors.
“Where we’ve chosen to lead is with a measurement nobody else can do at all,” he said. “The blue ocean, if you like.”
That focused entry point shapes PPB’s wider strategy. CYBERTONGUE® could eventually test for lactose, allergens, microbial toxins and other targets. Yet launching everything at once would stretch a six-person company too far. Protease gives it a clear route into dairy, where the financial value is easier to demonstrate.
A processor that detects high protease activity may redirect a batch of milk away from long-life products and use it for yoghurt, curd or another product where the enzyme causes less damage. PPB also says its tests can help trace problems in the milk supply and detect biofilms on processing equipment, allowing factories to take corrective cleaning measures.
Fresh milk presents another sizeable opportunity, with the global market estimated at around US$81 billion in 2026 and projected to grow at 6.83% annually through 2035. At that scale, even small gains in shelf-life consistency could prevent substantial losses. Supermarkets often require milk to have a minimum amount of shelf life remaining on delivery. Products that fall short may be rejected, discounted or discarded at the processor’s expense. While Australian processors typically aim for a shelf life of 19 to 21 days, they do not always achieve it. CYBERTONGUE® could help them reach that target more consistently.
Cheese producers face a related issue. Protease can create bitter flavours in hard cheeses and reduce production yield. Cheesemakers add another enzyme, chymosin, during production, often without knowing how much protease activity is already present in the milk. Better information could help them adjust the process and get more value from the same raw material.
PPB sells the reader as laboratory equipment, but its long-term business model centres on repeat testing. Customers buy the machine, then purchase a PPB reagent cartridge each time they run an assay. Future tests are intended to work on the same reader, making the system more useful as the catalogue expands.
CYBERTONGUE®’s compact design reflects PPB’s focus on practical onsite testing. The device is small enough to fit into two cupped hands and comes with a tablet running PPB’s software.
At the time of the interview, 13 to 15 systems had been installed with paying customers. PPB had made sales in 11 countries across five continents, with Europe as its largest market.
Trowell describes PPB as “born global”. While Australia and New Zealand have sophisticated dairy industries, Trowell thinks CYBERTONGUE® may offer even more value in regions where milk quality is less consistent, transport routes are longer or refrigeration is harder to maintain.
Trowell also believes PPB has a strong competitive moat, with the combination of manufacturing both the hardware and consumable reagents. Patents form one layer, but he does not consider legal protection sufficient on its own. A competitor would need expertise in protein engineering, reagent production, optical hardware, software and dairy processing.
Calibration adds another barrier. For each new box of reagents, PPB securely uploads the required calibration data to the customer’s machine. A third party could not simply manufacture a cartridge with the same dimensions and expect it to work correctly.
“We own the whole stack,” Trowell said, referring to everything from the sensing molecule to the hardware, software and cloud platform.
That said, he accepts that no technology is impossible to copy. His view is that PPB’s mix of scientific knowledge, integrated system and experience in dairy gives it enough of a head start to build a meaningful position before competitors catch up.
The technology could eventually reach beyond food. Trowell sees possible uses in environmental testing, veterinary care and medical diagnostics, including the analysis of blood, serum or saliva. PPB has already discussed potential applications with organisations outside the food industry.
For now, however, moving directly into clinical diagnostics would create more risk than opportunity. Medical products can require years of trials, extensive regulatory work and large development budgets. PPB would also need to build new sales channels and choose between many possible clinical uses without knowing which one would attract the strongest demand.
For these reasons, food testing offers PPB a clearer path. The regulatory barriers are generally lower, customers have immediate operational problems, and PPB has already built relationships in dairy. Once the platform has proved itself commercially, the company could enter other sectors through partnerships or licensing.
Trowell has held that view for years. The immediate goal is to build a successful food testing company rather than chase the prestige often attached to medical biotechnology.
The opportunity may also expand as food production becomes more complex. Dairy factories increasingly process oat, soy and other alternatives on equipment that also handles cow’s milk. This creates cross-contamination and allergen risks, offering another potential use for CYBERTONGUE®.
PPB still has plenty to prove. It must secure repeat reagent orders, convert early trials into wider deployments and expand its test catalogue without compromising accuracy. Scaling an integrated biotech hardware business across international markets will not be simple.
Still, its approach offers a useful lesson for other deep-tech startups. Instead of beginning with every possible application, PPB picked a specific problem that costs customers money today. It built a product around that pain point, then used the same technology as the foundation for a broader platform.
As Trowell put it, customers “need it fast, and they need it right.” CYBERTONGUE® is betting that food testing can deliver both.